Your browser doesn't support javascript.
loading
ISAR Consensus Guidelines on Safety and Ethical Practices in In vitro Fertilization Clinics.
Malhotra, Jaideep; Malhotra, Keshav; Talwar, Pankaj; Kannan, Priya; Singh, Prabhakar; Kumar, Yogesh; Chimote, Nishad; Joshi, Charudutt; Bawle, Sachin; Agarwal, R B; Agarwal, Saroj; Prakash, Ved; Awasthi, Pooja; Shukla, Sanjay; Prakash, Ram; Adiga, Satish Kumar.
Afiliação
  • Malhotra J; Managing Director, Rainbow IVF, Agra, Uttar Pradesh, President ISAR (2019), India.
  • Malhotra K; MBBS, MCE, Chief Embryologist & Director-Rainbow IVF, Agra (Uttar Pradesh), India.
  • Talwar P; Col (Prof), VSM, Head Medical Services, Birla Fertility and IVF, Gurgaon, India.
  • Kannan P; IVF Lab Director, Garbba Raksshambigai Fertility Centre, Chennai, Tamilnadu, India.
  • Singh P; MSc clin emb, Senior clin Embryologist, 21 Century IVF Centre, Surat Vapi Killa Pardi, Gujarat, India.
  • Kumar Y; Senior Clinical Embryologist, Faculty of Medical Sciences, University of Delhi, Former Clinical Embryologist & Research Associate IVF Centre MAMC & LN Hospital Delhi, India.
  • Chimote N; M.Sc Clinemb, Scientific Director, Vaunshdhara's Fertility Centre Pvt Ltd, Indore, Madhya Pradesh, India.
  • Joshi C; Lab Director, Genes India, The ART bank, Indore, Madhya Pradesh, India.
  • Bawle S; Lab Director and Clinical Embryologist, Dr. Sudha Tandon's Fertility, IVF, Endoscopy and Maternity Center, Mumbai, Maharashtra, India.
  • Agarwal RB; Director Ashoka Superspeciality Hospital, Senior Embryologist Ashoka Advanced IVF Unit, Raipur, Chattisgarh, India.
  • Agarwal S; Scientific Director & Senior Embryologist, Renovare Health Care, Kolkata, West Bengal, India.
  • Prakash V; Lab Director, Southend Fertility & IVF, Delhi-NCR, Noida, UP, India.
  • Awasthi P; Sr. consultant Embroyologist, Freelancer, Noida, UP, India.
  • Shukla S; Lab Director, Baheti Hospital & Centre for Reproductive Healthcare, Jaipur; Shivani Fertility & IVF Centre, Jaipur, Rajasthan, India.
  • Prakash R; Embryology Lab Director, Omya Fertility Center, New Delhi, India.
  • Adiga SK; Professor; Head, Dept. of Reproductive Science, Head, Division of Clinical Embryology, Coordinator, Centre for Fertility Preservation, Kasturba Medical College I Manipal Academy of Higher Education, Manipal, Karnataka, India.
J Hum Reprod Sci ; 14(Suppl 1): S48-S68, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34975245
STUDY QUESTION: What are the Safe and Ethical practices for ART applicable in INDIA? WHAT IS ALREADY KNOWN: The Indian IVF industry is booming; with mushrooming of assisted reproductive technology (ART) clinics in the country, the need for regulation is immense. The ISAR has taken up this initiative to lead the way forward in establishing practice guidelines for the safe and ethical use of ARTs in our country. These guidelines discuss the points to consider before the starting of an IVF unit, to the designing of the laboratory, the staffing pattern and experience recommendations, laboratory safety guidelines, documentation and patient traceability, gamete traceability, handling biological material, the consumables and media, and different consents and checklists and also propose key performance indicators for the Indian scenario. STUDY DESIGN SIZE DURATION: This is the report of a 2-day consensus meeting where two moderators were assigned to a group of experts to collate information on safe and ethical ivf practices in INDIA. This meeting utilised surveys, available scientific evidence and personal laboratory experience into various presentations by experts on pre-decided specific topics. PARTICIPANTS/MATERIALS SETTING METHODS: Expert professionals from ISAR representing clinical and embryology fields. MAIN RESULTS AND THE ROLE OF CHANCE: The report is divided in various components including the regulations, the various requirements for an ART center, qualifications and trainings, recommendations on good practices and quality management: the report and recommendations of the expert panel reflect the discussion on each of the topics and try to lay down good practice points for labs to follow. LIMITATIONS REASONS FOR CAUTION: The recommendations are solely based on expert opinion. Future availability of data may warrant an update of the same. WIDER IMPLICATIONS OF THE FINDINGS: These guidelines can help labs across the country to standardise their ART services and improve clinical outcomes. STUDY FUNDING/COMPETING INTERESTS: The consensus meeting and writing of the paper was supported by funds from CooperSurgical India.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article